Want to see RXST full AI Analyst Report?
Total Valuation
RxSight has a market cap or net worth of $291.57M. The enterprise value is $1.77.
Market Cap$291.57M
Enterprise Value$1.77
Share Statistics
RxSight has 41,593,258 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,593,258
Owned by Insiders6.33%
Owned by Institutions14.87%
Financial Efficiency
RxSight’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -16.81%.
Return on Equity (ROE)-0.14
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-16.81%
Return on Capital Employed (ROCE)-0.17
Revenue Per Employee291.71K
Profits Per Employee-84.48K
Employee Count461
Asset Turnover0.43
Inventory Turnover1.00
Valuation Ratios
The current PE Ratio of RxSight is ―. RxSight’s PEG ratio is -0.32.
PE Ratio―
PS Ratio3.19
PB Ratio1.56
Price to Fair Value1.56
Price to FCF-22.18
Price to Operating Cash Flow-12.58
PEG Ratio-0.32
Income Statement
In the last 12 months, RxSight had revenue of 134.48M and earned -38.94M in profits. Earnings per share was -0.95.
Revenue134.48M
Gross Profit103.01M
Operating Income-48.19M
Pretax Income-38.88M
Net Income-38.94M
EBITDA-38.84M
Earnings Per Share (EPS)-0.95
Cash Flow
In the last 12 months, operating cash flow was -22.73M and capital expenditures -4.43M, giving a free cash flow of -27.16M billion.
Operating Cash Flow-22.73M
Free Cash Flow-27.16M
Free Cash Flow per Share-0.65
Dividends & Yields
RxSight pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.22
52-Week Price Change-18.27%
50-Day Moving Average5.46
200-Day Moving Average7.76
Relative Strength Index (RSI)70.64
Average Volume (3m)1.34M
Important Dates
RxSight upcoming earnings date is Nov 11, 2026, After Close (Confirmed).
Last Earnings DateAug 5, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date―
Financial Position
RxSight as a current ratio of 10.95, with Debt / Equity ratio of 4.02%
Current Ratio10.95
Quick Ratio9.75
Debt to Market Cap0.02
Net Debt to EBITDA0.23
Interest Coverage Ratio-1.20K
Taxes
In the past 12 months, RxSight has paid 66.00K in taxes.
Income Tax66.00K
Effective Tax Rate>-0.01
Enterprise Valuation
RxSight EV to EBITDA ratio is -10.82, with an EV/FCF ratio of -21.72.
EV to Sales3.12
EV to EBITDA-10.82
EV to Free Cash Flow-21.72
EV to Operating Cash Flow-27.09
Balance Sheet
RxSight has $208.80M in cash and marketable securities with $10.58M in debt, giving a net cash position of $198.22M billion.
Cash & Marketable Securities$208.80M
Total Debt$10.58M
Net Cash$198.22M
Net Cash Per Share$4.77
Tangible Book Value Per Share$6.70
Margins
Gross margin is 77.50%, with operating margin of -35.84%, and net profit margin of -28.96%.
Gross Margin77.50%
Operating Margin-35.84%
Pretax Margin-28.91%
Net Profit Margin-28.96%
EBITDA Margin-28.88%
EBIT Margin-28.88%
Analyst Forecast
The average price target for RxSight is $7.79, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$7.79
Price Target Upside50.05% Upside
Analyst ConsensusHold
Analyst Count10
Revenue Growth Forecast-13.24%
EPS Growth Forecast-42.62%